Oncolytics Biotech

Biotech Stock News: Oncolytics Biotech, Inc. (USA), Horizon Pharma PLC, Depomed Inc, Celgene Corporation

By Terry Chrisomalis Oncolytics Biotech, Inc. (USA) On July 6, 2015 shares of Oncolytics Biotech, Inc.

CNA Finance — July 14, 2015, 12:10 PM EDT

Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Collaborators Present REOLYSIN® Preclinical Data at the 9th International Conference on Oncolytic Virus Therapeutics

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that a series of oral and poster presentations are being made by the Company’s research collaborators at …

Corey Williams — June 15, 2015, 6:50 AM EDT

Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Director Election Results from its Annual Meeting of Shareholders

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that all nominees listed in the management information circular dated May 6, 2015 were elected as directors at …

Corey Williams — June 9, 2015, 6:46 AM EDT

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Provides Update at AGM on Planned Registration Program for REOLYSIN

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) provided an update on its planned registration program for REOLYSIN®, its proprietary formulation of the human reovirus, at its Annual …

Corey Williams — June 8, 2015, 4:18 PM EDT

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Phase 1 Study in Pediatric Patients with Brain Tumors

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that following submission to the U.

Corey Williams — May 19, 2015, 6:35 AM EDT

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Receipt of Orphan Drug Status from the EMA for Pancreatic Cancer

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, announced that the European …

Corey Williams — April 29, 2015, 6:33 AM EDT

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Receipt of Orphan Drug Designation from the U.S. FDA for Malignant Gliomas

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that …

Corey Williams — April 17, 2015, 8:09 AM EDT